BG91463A - Холестираминова таблетка и метод за получаването й - Google Patents

Холестираминова таблетка и метод за получаването й

Info

Publication number
BG91463A
BG91463A BG091463A BG9146390A BG91463A BG 91463 A BG91463 A BG 91463A BG 091463 A BG091463 A BG 091463A BG 9146390 A BG9146390 A BG 9146390A BG 91463 A BG91463 A BG 91463A
Authority
BG
Bulgaria
Prior art keywords
core
weight
agglomerates
tablet
cholestyramine
Prior art date
Application number
BG091463A
Other languages
English (en)
Other versions
BG60501B1 (bg
Inventor
Robert Bequette
Bruce Bonenberger
Claude Gallian
John Reckelhoff
Original Assignee
Bristol - Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol - Myers Squibb Company filed Critical Bristol - Myers Squibb Company
Publication of BG91463A publication Critical patent/BG91463A/bg
Publication of BG60501B1 publication Critical patent/BG60501B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Изобретението намира приложение във фармацевтичната промишленост. Таблетката се състои от сърцевина от холестираминови агломерати с обемно тегло в уплътнено състояние 0,45-0,5 г/мл и влагосъдържание от 8 до 14% тегловни. Агломератите са образувани от много малки, неправилно оформени с остри начупени краища с относително малко на брой големи гладки или плоски повърхности, като сърцевината има твърдост от 18 до 26 sсu, свободно от разтворител покритие, което включва в тегл.% От 60 до 95 стеаринова киселина, от 5 до 40 полиетиленгликол и от 10 до 20 частично хидрирано соево масло. По метода омокрените холестираминови частици се смилат в мелница за микронизиране и смлените частици се сушат при температура от 48 до 580с до влагосъдържание от 8 до 14% тегловни. Изсушеният материал се фракционира, при което се получават холестираминови агломерати, които се пресуват директно за получаване на сърцевина на таблетката. Върху сърцевината се нанася покритието, свободно от разтворител. 5 претенции
BG91463A 1989-03-16 1990-03-14 Холестираминова таблетка и метод за получаванетой BG60501B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,167 US4956182A (en) 1989-03-16 1989-03-16 Direct compression cholestyramine tablet and solvent-free coating therefor

Publications (2)

Publication Number Publication Date
BG91463A true BG91463A (bg) 1993-12-24
BG60501B1 BG60501B1 (bg) 1995-06-30

Family

ID=23262387

Family Applications (1)

Application Number Title Priority Date Filing Date
BG91463A BG60501B1 (bg) 1989-03-16 1990-03-14 Холестираминова таблетка и метод за получаванетой

Country Status (34)

Country Link
US (1) US4956182A (bg)
EP (1) EP0387885B1 (bg)
JP (1) JP2974719B2 (bg)
KR (1) KR0140211B1 (bg)
CN (1) CN1047935C (bg)
AR (1) AR246012A1 (bg)
AT (1) ATE128031T1 (bg)
AU (1) AU617601B2 (bg)
BG (1) BG60501B1 (bg)
CA (1) CA2012300A1 (bg)
CS (1) CS277488B6 (bg)
CY (1) CY1899A (bg)
DD (1) DD292837A5 (bg)
DE (1) DE69022452T2 (bg)
DK (1) DK0387885T3 (bg)
EG (1) EG19669A (bg)
ES (1) ES2078917T3 (bg)
FI (1) FI92464C (bg)
GR (1) GR3017460T3 (bg)
HK (1) HK51396A (bg)
HU (1) HU209958B (bg)
IE (1) IE70591B1 (bg)
IL (1) IL93720A0 (bg)
MY (1) MY109744A (bg)
NO (1) NO176043C (bg)
NZ (1) NZ232864A (bg)
OA (1) OA09198A (bg)
PL (1) PL163301B1 (bg)
PT (1) PT93452B (bg)
RO (1) RO106953B1 (bg)
RU (1) RU2069558C1 (bg)
YU (1) YU52390A (bg)
ZA (1) ZA902001B (bg)
ZW (1) ZW1890A1 (bg)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
JP4334616B2 (ja) * 1994-09-22 2009-09-30 ナームローゼ・フエンノートチヤツプ・オルガノン 湿式粒状化による投与単位体を製造する方法
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
EP1126826B3 (en) 1998-11-02 2019-05-15 Alkermes Pharma Ireland Limited Multiparticulate modified release composition of methylphenidate
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
IL157075A0 (en) * 2001-02-13 2004-02-08 Astrazeneca Ab Novel modified release formulation
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
CA2461616A1 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
RU2234915C2 (ru) * 2002-06-04 2004-08-27 Дж. Б. Кемикалс энд Фармасьютикалс Лтд. Твердая фармацевтическая композиция для перорального введения и способ ее получения
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
ES2400186T3 (es) * 2004-05-24 2013-04-08 Mepha Schweiz Ag Procedimiento para recubrimiento en seco
ATE415148T1 (de) * 2004-10-19 2008-12-15 Krka Tovarna Zdravil D D Novo Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP3000460A1 (en) 2005-09-15 2016-03-30 Genzyme Corporation Sachet formulation for amine polymers
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
EP2050456A4 (en) * 2006-08-09 2013-01-23 Mitsubishi Tanabe Pharma Corp COMPRESSED
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
ES2699806T3 (es) 2012-04-18 2019-02-12 SpecGx LLC Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata
CN105848894B (zh) 2013-10-25 2018-01-23 株式会社可乐丽 多层薄膜和包含其的夹层玻璃用中间膜
PT3164117T (pt) 2014-07-03 2023-12-12 SpecGx LLC Formulações de libertação imediata de dissuasão de abuso compreendendo polissacáridos não celulósicos
EP3413877B1 (en) * 2016-02-09 2021-04-07 Albireo AB Oral cholestyramine formulation and use thereof
CA3011595C (en) * 2016-02-09 2024-01-02 Albireo Ab Cholestyramine pellets and methods for preparation thereof
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
CY1899A (en) 1990-03-15
JP2974719B2 (ja) 1999-11-10
NO176043C (no) 1995-01-25
HK51396A (en) 1996-03-29
US4956182A (en) 1990-09-11
FI901241A0 (fi) 1990-03-13
PL163301B1 (en) 1994-03-31
IL93720A0 (en) 1990-12-23
NO176043B (no) 1994-10-17
KR900013946A (ko) 1990-10-22
OA09198A (fr) 1992-06-30
CN1045921A (zh) 1990-10-10
ZW1890A1 (en) 1990-10-31
ZA902001B (en) 1990-11-28
EG19669A (en) 1995-08-30
HUT54489A (en) 1991-03-28
KR0140211B1 (ko) 1998-06-01
HU901429D0 (en) 1990-06-28
GR3017460T3 (en) 1995-12-31
EP0387885B1 (en) 1995-09-20
CN1047935C (zh) 2000-01-05
YU52390A (en) 1991-10-31
BG60501B1 (bg) 1995-06-30
IE70591B1 (en) 1996-12-11
PT93452B (pt) 1996-12-31
DK0387885T3 (da) 1995-11-06
DE69022452T2 (de) 1996-03-14
NO901183L (no) 1990-09-17
MY109744A (en) 1997-05-31
ES2078917T3 (es) 1996-01-01
PT93452A (pt) 1990-11-07
RO106953B1 (ro) 1993-08-30
ATE128031T1 (de) 1995-10-15
AU617601B2 (en) 1991-11-28
EP0387885A2 (en) 1990-09-19
HU209958B (en) 1994-12-28
FI92464B (fi) 1994-08-15
DD292837A5 (de) 1991-08-14
EP0387885A3 (en) 1992-06-17
IE900941L (en) 1990-09-16
AR246012A1 (es) 1994-03-30
CA2012300A1 (en) 1990-09-16
RU2069558C1 (ru) 1996-11-27
FI92464C (fi) 1994-11-25
DE69022452D1 (de) 1995-10-26
JPH03236326A (ja) 1991-10-22
NO901183D0 (no) 1990-03-14
CS277488B6 (en) 1993-03-17
AU5136790A (en) 1990-09-20
NZ232864A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
BG91463A (bg) Холестираминова таблетка и метод за получаването й
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
FR2675398B1 (fr) Micro-capsules de filtres solaires, leur procede de preparation, les compositions cosmetiques et pharmaceutiques les comprenant et leurs applications.
NO176504C (no) Fremgangsmåte for fremstilling av en kosmetisk blanding
BE884992A (fr) Procede de preparation de suspensions ou de poudres stables de microcapsules stables et d'une porosite variable et produits ainsi obtenue
ES2053746T3 (es) Composicion para el tratamiento de la piel.
NL930095I1 (nl) Aromatische heterocyclische esters van steroïden de bereiding daarvan en farmaceutische composities die deze verbindingen bevatten
ES2165508T3 (es) Material polimerico, procedimiento para su fabricacion y su uso.
BE875217A (fr) Nouvelles oximes 0-substituees de l'acide 7-amino thiazolyl acetamido cephalosporanque, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
NO174062C (no) Fremgangsmåte for fremstilling av blekende granulat, samt anvendelse av granulatet
BR9406670A (pt) Composiçoes concentradas sólidas sistema de conteinerização e processo de preparação de uma mistura
Alder et al. Electrophoretic analysis of liver and testis histones of the frog Rana pipiens.
Perrie et al. A phosphorylated light-chain component of myosin
MX155639A (es) Composicion para matar el lustre de barnices a base de cera y procedimiento para su preparacion
ES8507152A1 (es) Un procedimiento para producir aditivos a piensos para animales
FR2570604B1 (fr) Nouveau procede d'encapsulation de substances volatiles et les compositions phyto-aromatiques ainsi obtenues
DE3567013D1 (en) Perfume compositions and perfumed products which contain one or more 4,7-alkadienals as the essential substance
FR2556721B1 (fr) Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2573077B1 (fr) Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant
IT1171387B (it) Derivati steroidici 20-isonitrili 17(20)-insaturi, procedimento per la loro preparazione, e loro applicazione nella preparazione degli sterioidi 17alfa-idrcssi-20-chetonici
EP0348215A3 (en) Novel cosmetic and paramedicinal compositions
WO1990007260A3 (en) 2,3-methanoproline
FI891477L (fi) Anvaendning av torv och material foer isoleringsaendamaol till exempel.
IT1231764B (it) Composizione poliuretanica con capacita' di assorbire umidita', particolarmente adatta per la fabbricazione di cuoio sintetico e simili, e procedimento per la sua produzione.
ES2034392T3 (es) Un producto granular.